Free Trial

STAAR Surgical (STAA) Stock Price, News & Analysis

STAAR Surgical logo
$17.02 +0.24 (+1.43%)
Closing price 04:00 PM Eastern
Extended Trading
$17.00 -0.02 (-0.12%)
As of 06:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About STAAR Surgical Stock (NASDAQ:STAA)

Key Stats

Today's Range
$16.40
$17.72
50-Day Range
$16.34
$20.27
52-Week Range
$13.50
$49.86
Volume
827,203 shs
Average Volume
857,468 shs
Market Capitalization
$843.00 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$24.63
Consensus Rating
Hold

Company Overview

STAAR Surgical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
82nd Percentile Overall Score

STAA MarketRank™: 

STAAR Surgical scored higher than 82% of companies evaluated by MarketBeat, and ranked 222nd out of 943 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    STAAR Surgical has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, 9 hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    STAAR Surgical has only been the subject of 4 research reports in the past 90 days.

  • Read more about STAAR Surgical's stock forecast and price target.
  • Earnings Growth

    Earnings for STAAR Surgical are expected to grow in the coming year, from ($1.14) to ($0.04) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of STAAR Surgical is -11.82, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of STAAR Surgical is -11.82, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    STAAR Surgical has a P/B Ratio of 2.11. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about STAAR Surgical's valuation and earnings.
  • Percentage of Shares Shorted

    13.36% of the float of STAAR Surgical has been sold short.
  • Short Interest Ratio / Days to Cover

    STAAR Surgical has a short interest ratio ("days to cover") of 7.4.
  • Change versus previous month

    Short interest in STAAR Surgical has recently increased by 17.17%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    STAAR Surgical does not currently pay a dividend.

  • Dividend Growth

    STAAR Surgical does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    13.36% of the float of STAAR Surgical has been sold short.
  • Short Interest Ratio / Days to Cover

    STAAR Surgical has a short interest ratio ("days to cover") of 7.4.
  • Change versus previous month

    Short interest in STAAR Surgical has recently increased by 17.17%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    STAAR Surgical has a news sentiment score of 0.99. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.89 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for STAAR Surgical this week, compared to 6 articles on an average week.
  • Search Interest

    17 people have searched for STAA on MarketBeat in the last 30 days. This is an increase of 70% compared to the previous 30 days.
  • MarketBeat Follows

    3 people have added STAAR Surgical to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, STAAR Surgical insiders have bought more of their company's stock than they have sold. Specifically, they have bought $10,749,914.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    Only 1.00% of the stock of STAAR Surgical is held by insiders.

  • Percentage Held by Institutions

    96.70% of the stock of STAAR Surgical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about STAAR Surgical's insider trading history.
Receive STAA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for STAAR Surgical and its competitors with MarketBeat's FREE daily newsletter.

STAA Stock News Headlines

"I'm risking my reputation on this"
Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the same signals. They're positioning themselves for something unprecedented. And after 17 million podcast downloads and over 600 insider interviews, I finally connected all the dots… What I discovered was so explosive, so potentially life-changing, that I had to put it all in a book.
Staar Surgical Holds Annual Shareholders Meeting
See More Headlines

STAA Stock Analysis - Frequently Asked Questions

STAAR Surgical's stock was trading at $24.29 on January 1st, 2025. Since then, STAA stock has decreased by 29.9% and is now trading at $17.02.
View the best growth stocks for 2025 here
.

STAAR Surgical Company (NASDAQ:STAA) announced its earnings results on Wednesday, August, 7th. The medical instruments supplier reported $0.15 earnings per share for the quarter, missing analysts' consensus estimates of $0.24 by $0.09. STAAR Surgical's quarterly revenue was up 7.3% on a year-over-year basis.
Read the conference call transcript
.

STAAR Surgical's board authorized a stock buyback plan on Friday, May 16th 2025, which allows the company to repurchase $30,000,000 in outstanding shares, according to EventVestor. This means that the company could repurchase up to 3.2% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company's board believes its stock is undervalued.

STAAR Surgical subsidiaries include Canon Staar, Frigitronics Inc., STAAR Japan Inc., STAAR Optical Equipment, STAAR Surgical AG, STAAR Surgical PTE. LTD, and Technology (Shanghai) Co. LTD.

Shares of STAA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that STAAR Surgical investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Netflix (NFLX), Palo Alto Networks (PANW) and JPMorgan Chase & Co. (JPM).

Company Calendar

Last Earnings
8/07/2024
Today
7/01/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED/DENTAL - SUPP
Sub-Industry
Health Care Supplies
Current Symbol
NASDAQ:STAA
Employees
1,211
Year Founded
1982

Price Target and Rating

Average Stock Price Target
$24.63
High Stock Price Target
$53.00
Low Stock Price Target
$16.00
Potential Upside/Downside
+44.2%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
11 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$20.21 million
Pretax Margin
-21.97%

Debt

Sales & Book Value

Annual Sales
$313.90 million
Price / Cash Flow
N/A
Book Value
$8.06 per share
Price / Book
2.12

Miscellaneous

Free Float
49,031,000
Market Cap
$845.68 million
Optionable
Optionable
Beta
0.63

Social Links

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:STAA) was last updated on 7/1/2025 by MarketBeat.com Staff
From Our Partners